Showing 1 - 3 results of 3 for search 'Fatema Nader', query time: 0.02s Refine Results
  1. 1
    Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D Instruments

    Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Fo... by Zobair M. Younossi, Maria Stepanova, Yestle Kim, Stephen Dodge, Dominic Labriola, Rebecca Taub, Fatema Nader

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)

    Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK) by Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region

    Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region by Saleh A. Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, Khalid Alswat, Mohamed Mawardi, Faisal M. Sanai, Faisal Abaakhail, Saad Alghamdi, Waleed K. Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M. Younossi

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: